Cost comparison by treatment arm and center‐level variations in cost and inpatient days on the phase <scp>III</scp> high‐risk B acute lymphoblastic leukemia trial <scp>AALL</scp>0232Amanda M. DiNofia, Richard Aplenc, Meenakshi Devidas et al.|Cancer Medicine|2017Cited by 14